Lymphedema, or persistent swelling of the leg, is the most common and most disruptive long-term side effect of lymph node removal in the groin. Depending on the extent of surgery, roughly a quarter to nearly three-quarters of patients develop some degree of it, and the consequences ripple outward into chronic infections, reduced mobility, pain, and diminished quality of life. The groin is a uniquely vulnerable area because the lymph nodes there serve as the primary drainage hub for the entire lower limb, so removing them disrupts a system with limited backup routes.
Why the Groin Is a High-Risk Area
The superficial inguinal lymph nodes in the groin can be divided into three clusters based on which body region they drain: one group handles lymph from the lower abdomen, one from the inner thigh, and one from the outer thigh. Anatomical dissections have shown that the nodes responsible for draining the leg sit in the lower part of this triangle, with their outflow channels running alongside the femoral artery. There are no connections between the superficial and deep lymphatic systems in the groin region, meaning once the superficial nodes are removed, the leg’s lymphatic fluid has very few alternative pathways.
This anatomy explains why groin dissections carry a higher complication burden than lymph node removals in most other body sites. The more nodes a surgeon takes out, the more skin lymphatic channels and small blood vessels are damaged in the process, compounding the drainage problem.
Lymphedema and How It Develops
After inguinal lymph node dissection, the onset of lymphedema is typically gradual. Patients first notice a heavy, tight, or achy feeling in the affected leg, followed by progressive swelling. In early stages, pressing a finger into the swollen area leaves a temporary dent, sometimes called pitting edema. Over time, the tissue can become firmer as protein-rich fluid accumulates and triggers inflammation and scarring within the skin and fat.
How common is it? That depends heavily on the type and extent of surgery. A systematic review and meta-analysis of studies involving inguinal lymphadenectomy estimated a pooled lymphedema rate of about 29% after full node dissection for vulvar cancer, though rates in prospective studies were closer to 17%. In melanoma patients who underwent a complete groin dissection after a positive sentinel node biopsy, the rate of even slight lymphedema reached 64% in one European cohort. By contrast, patients who had only the sentinel node removed experienced lymphedema about 6% of the time. A study from northeast India reported lymphedema as the most frequent complication of groin dissection, affecting about a quarter of patients overall.
The risk factors that push a person toward lymphedema include the number of nodes removed, wound infection after surgery, higher body mass index, older age, and whether radiation therapy was also given to the groin area. A retrospective melanoma cohort study found that more extensive dissection leads to more widespread damage to the skin’s lymphatic channels, which makes intuitive sense: the bigger the surgery, the fewer drainage routes remain intact.
Recurrent Skin Infections
Once the lymphatic system in the leg is compromised, the limb becomes vulnerable to repeated bacterial skin infections, most commonly cellulitis. Lymph fluid that pools in tissue is an ideal breeding ground for bacteria, and the impaired immune surveillance that comes with fewer lymph nodes makes it harder for the body to contain an infection once it starts.
In a study of patients who had inguinal lymphadenectomy for gynecologic cancers, about 22% developed cellulitis more than 30 days after surgery, making it one of the most common late complications. Late lymphedema occurred in about 30% of patients, and those who had cellulitis early on were at substantially higher risk of wound breakdown and lymphocyst formation. These infections tend to recur. Some patients find themselves on antibiotics multiple times a year, and each bout of cellulitis further damages the already struggling lymphatic vessels, creating a vicious cycle of worsening swelling and more infections.
Fluid Collections That Linger
Lymphoceles, which are pockets of lymphatic fluid that collect under the skin near the surgical site, are a frequent early complication of groin node dissection. While many resolve on their own or with drainage, some persist or recur once a patient returns to normal activity. Case reports describe lymphoceles in the groin worsening after patients resume work, sometimes requiring multiple sessions of a treatment called sclerotherapy (injection of an irritant to collapse the cavity) before finally resolving.
Seromas, which are similar fluid collections but composed mainly of blood serum, are another common issue. In one melanoma cohort, seroma was the single most frequent complication after sentinel node biopsy alone, occurring in about 15% of cases. After full groin dissection, both seromas and lymphoceles can delay wound healing and increase infection risk, sometimes extending recovery by weeks or months.
Blood Clot Risk
The groin dissection itself carries a notable risk of deep vein thrombosis. In an older but frequently cited study of patients undergoing inguinal lymph node dissection for melanoma, the combined incidence of deep vein thrombosis and pulmonary embolism was about 14%. The surgery involves working in close proximity to the femoral vein, and the postoperative period of reduced mobility, combined with local tissue inflammation, creates ideal conditions for clot formation. Modern protocols using blood thinners and early mobilization have reduced this risk, but it remains something surgeons actively monitor for in the weeks following the procedure.
Nerve Damage and Chronic Pain
The groin is a busy intersection of nerves, including the femoral nerve and its branches. Groin dissection can injure these structures, leading to numbness, tingling, or burning sensations along the inner thigh and leg. In some cases, the nerve injury triggers a condition called complex regional pain syndrome, where chronic pain, swelling, and skin changes develop in the affected limb and persist long after the surgical wound has healed. This outcome is relatively rare but can be severely disabling when it occurs.
Even without a formal pain syndrome diagnosis, many patients report persistent discomfort around the surgical scar and in the upper thigh. One melanoma cohort found significant limitations in both hip flexion and hip abduction (the ability to move the leg outward) in patients who had full groin dissection compared to those who had sentinel node biopsy alone. These movement restrictions may be partly muscular and partly related to nerve damage near the surgical site.
How Lymphedema Affects Daily Life
The physical and emotional burden of lymphedema after groin surgery goes well beyond a swollen leg. A study of 174 patients who had undergone inguinal lymphadenectomy found that those with lymphedema-related symptoms scored significantly lower on virtually every measure of quality of life compared to those without symptoms. Patients with symptoms had a mean physical component score of about 46 on a standardized health survey, versus roughly 56 for symptom-free patients, and the gap was similar for mental health scores. Those with lymphedema also reported more problems with mobility, self-care, and everyday activities, along with higher levels of pain, anxiety, and depression. On a lower-extremity function questionnaire, patients with lymphedema symptoms scored a mean of about 58 out of 80, compared to about 76 for those without symptoms, reflecting real limitations in walking, standing, climbing stairs, and other daily tasks.
In women treated for vulvar cancer with complete lymph node removal, about 73% reported leg swelling in a quality-of-life survey, with roughly a third describing it as moderate and about 12% calling it severe. The greatest negative impacts were on sex life, physical function, and social activities. Women who also received radiation to the groin had even higher rates, with 80% of those who had radiotherapy reporting lymphedema. These numbers highlight that for many patients, groin lymph node removal is not a one-time surgical event but the beginning of a chronic condition that reshapes daily life.
Sentinel Node Biopsy Versus Full Dissection
The single biggest factor in long-term side effects is how many nodes are removed. Sentinel lymph node biopsy, where a surgeon identifies and removes only the first one or two nodes that drain from the tumor, was developed specifically to reduce the collateral damage of full dissection. Large prospective trials in vulvar cancer, including GROINSS-V and GOG-173, demonstrated that sentinel node biopsy is both safe from a cancer standpoint and dramatically less morbid than removing all the groin nodes.
The difference in complication rates is striking. In a melanoma study, overall complications occurred in about 22% of patients who had sentinel biopsy alone, compared to 47% of those who went on to full dissection. Lymphedema specifically jumped from around 6% with sentinel biopsy to about 21% after full dissection. In vulvar cancer, the lymphedema rate after full inguinofemoral dissection was roughly five times higher than after sentinel biopsy alone. Not every patient is a candidate for the less invasive approach; it works best when tumors are relatively small, unifocal, and the sentinel node is successfully identified. But when it is feasible, it spares patients an enormous amount of long-term suffering.
Managing Lymphedema Once It Develops
There is no cure for lymphedema, but there are effective ways to control it. The standard first-line treatment is called complete decongestive therapy, which combines manual lymphatic drainage (a specialized massage technique), compression garments or bandaging, skin care, and targeted exercise. A retrospective study of melanoma patients with lower-extremity lymphedema after groin dissection found significant improvements in swelling, disability, and symptoms with this approach. Even a reduced-frequency program of twice-weekly sessions produced measurable reductions in limb volume on the order of 9 to 10% in a case study of bilateral lower-extremity lymphedema.
The catch is that decongestive therapy is a lifelong commitment. Compression garments need to be worn daily, skin care must be meticulous to prevent infection, and the exercises are ongoing. The financial burden can be substantial; long-term lymphedema management involves recurring costs for garments, therapy visits, and sometimes specialized equipment, and insurance coverage varies widely.
Surgical Options for Established Lymphedema
For patients whose lymphedema does not respond adequately to conservative management, microsurgical techniques have emerged as promising treatments. Two approaches have gained the most traction: lymphovenous anastomosis, where a surgeon connects functioning lymphatic vessels directly to nearby veins to create new drainage routes, and vascularized lymph node transfer, where healthy lymph nodes from another part of the body are transplanted into the affected area.
A systematic review and meta-analysis found that both procedures significantly reduced the frequency of recurrent cellulitis episodes. In lower extremities specifically, lymphovenous anastomosis cut annual cellulitis events by about 1.3 per year, and vascularized lymph node transfer reduced them by about 1.4 per year. A study of laparoscopic omental lymph node flap transfer for lower-extremity lymphedema reported a 29% average reduction in limb circumference at about 28 months of follow-up. All seven patients in that study who had a history of recurrent lymphangitis (inflammation of lymphatic vessels) experienced complete resolution of those episodes after surgery. Patients also reported reduced heaviness and tightness in the leg, better skin quality, and improved tolerance for walking and prolonged standing.
An innovative approach being tested in vulvar cancer patients involves performing lymphatic reconstruction at the same time as the cancer surgery. In one series, patients who received a lymphatic flap during groin dissection had significantly less limb volume increase compared to the untreated side, with the flap-protected limb averaging about 7% volume increase versus about 10% on the unprotected side. Only 8 out of 33 treated limbs developed pitting edema, compared to 25 out of 33 untreated limbs. A randomized trial is now underway to formally test whether this prophylactic approach can prevent lymphedema rather than just treating it after the fact.
Imaging and Monitoring After Surgery
Detecting lymphedema early, before it becomes obvious to the naked eye, gives patients the best chance of controlling it. Near-infrared lymphangiography has become a valuable tool in this regard. It involves injecting a fluorescent dye into the skin and tracking its movement through the lymphatic vessels using a special camera. The technique can visualize individual lymphatic channels and identify transport problems, including a hallmark sign called dermal backflow, where lymph fluid reverses direction into the skin because the normal forward pathways are blocked. Catching dermal backflow before significant swelling develops allows for early intervention with compression and therapy, which is far more effective than starting treatment once lymphedema is entrenched.
Standardized limb circumference measurements at regular intervals after surgery remain the simplest monitoring method and are recommended at most cancer follow-up visits. Some centers have adopted bioimpedance spectroscopy, which measures fluid content in the limb by passing a small electrical current, as a more objective screening tool. The goal of any monitoring program is the same: catch the earliest signs of fluid accumulation before the tissue changes become permanent.
When the Cancer Type Matters
The underlying cancer diagnosis shapes both the extent of surgery and the profile of long-term complications. In melanoma, groin dissections tend to be performed either as completion dissections after a positive sentinel node or as therapeutic dissections for clinically apparent disease. The complication rates differ accordingly: in an Asian melanoma cohort, complications occurred in about 22% of sentinel-biopsy-only patients but jumped to 47% after completion dissection. In gynecologic cancers, particularly vulvar cancer, the dissection often extends deeper into the inguinofemoral nodes and may be bilateral, which multiplies the lymphedema risk. The pooled lymphedema estimate of about 29% after vulvar cancer surgery represents an average across varying surgical approaches, and individual risk can be much higher depending on how extensive the dissection was and whether radiation followed.
Penile cancer and some urologic malignancies also require inguinal lymph node dissection, and the complication profiles overlap substantially with those seen in melanoma and gynecologic cases. The common thread across all these cancers is that the long-term side effects are driven primarily by how much lymphatic tissue is removed and how much collateral damage occurs to surrounding structures, rather than by the cancer type itself.
The Financial Weight of a Chronic Condition
Lymphedema is expensive to live with. Compression garments need replacement every few months, manual lymphatic drainage sessions carry copays or out-of-pocket costs, and specialized skincare products add up over years. The full scope of these out-of-pocket expenses has been difficult to quantify because previous studies could not fully assess them, but research has consistently identified long-term lymphedema management as a significant financial burden on patients. For people who develop recurrent cellulitis, emergency department visits and courses of antibiotics add further costs. Those who eventually need microsurgical reconstruction face the expense of specialized procedures that are not universally covered by insurance. The economic toll compounds the physical and emotional one, and it is worth factoring into discussions about surgical planning and risk reduction whenever less extensive options like sentinel node biopsy are on the table.